Zepp Health Corporation Sponsored ADR $ZEPP Shares Sold by Trivest Advisors Ltd

Trivest Advisors Ltd lowered its stake in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) by 44.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 162,904 shares of the company’s stock after selling 132,043 shares during the period. Zepp Health accounts for 0.2% of Trivest Advisors Ltd’s investment portfolio, making the stock its 28th largest position. Trivest Advisors Ltd owned 1.12% of Zepp Health worth $4,389,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ZEPP. Public Employees Retirement System of Ohio acquired a new position in shares of Zepp Health in the 3rd quarter valued at $43,000. Oasis Management Co Ltd. acquired a new position in shares of Zepp Health in the 3rd quarter valued at $276,000. Capstone Capital Management Ltd acquired a new position in shares of Zepp Health in the 4th quarter valued at $298,000. Themes Management Co LLC acquired a new position in shares of Zepp Health in the 4th quarter valued at $489,000. Finally, Centiva Capital LP acquired a new position in shares of Zepp Health in the 3rd quarter valued at $538,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Fundamental Research set a $56.28 target price on Zepp Health and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $56.28.

Zepp Health Price Performance

Shares of NYSE ZEPP opened at $6.14 on Friday. Zepp Health Corporation Sponsored ADR has a 1-year low of $2.25 and a 1-year high of $61.85. The company has a market cap of $90.06 million, a price-to-earnings ratio of -2.44 and a beta of 1.78. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.02 and a quick ratio of 0.77. The stock’s 50-day moving average is $12.04 and its two-hundred day moving average is $19.56.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.